Bulk Manufacturer of Controlled Substances Registration, 60897 [2018-25875]
Download as PDF
<![CDATA[
60897
Federal Register / Vol. 83, No. 228 / Tuesday, November 27, 2018 / Notices
Controlled substance
Drug code
Schedule
Remifentanil .............................................................................................................................................................
9739
II
The company plans to import the
above listed controlled substance for
research purposes.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Administration (DEA) as bulk a
manufacturer of various classes of
schedule I and II controlled substances.
Dated: November 16, 2018.
John J. Martin,
Assistant Administrator.
[Docket No. DEA–392]
SUPPLEMENTARY INFORMATION:
Bulk Manufacturer of Controlled
Substances Registration
[FR Doc. 2018–25873 Filed 11–26–18; 8:45 am]
ACTION:
BILLING CODE 4410–09–P
Notice of registration.
The registrant listed below
has applied for and been granted
registration by the Drug Enforcement
SUMMARY:
The
company listed below applied to be
registered as bulk manufacturer of
various basic classes of controlled
substances. Information on the
previously published notice is listed in
the table below. No comments or
objections were submitted for this
notice.
Company
FR Docket
Rhodes Technologies .............................................................
83 FR 40567 ..........................................................................
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of this registrant to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed company.
Dated: November 16, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–25875 Filed 11–26–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Cambridge Isotope
Laboratories
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 27, 2018. Such
persons may also file a written request
for a hearing on the application on or
before December 27, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
DATES:
Published
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on August
30, 2018, Cambridge Isotope
Laboratories, 50 Frontage Road,
Andover, Massachusetts 01810 applied
to be registered as an importer of the
following basic classes of controlled
substances:
amozie on DSK3GDR082PROD with NOTICES1
Controlled substance
Drug code
Tetrahydrocannabinols ............................................................................................................................................
Gamma Hydroxybutyric Acid ...................................................................................................................................
Morphine ..................................................................................................................................................................
VerDate Sep<11>2014
17:45 Nov 26, 2018
Jkt 247001
PO 00000
Frm 00077
Fmt 4703
August 15, 2018.
Sfmt 4703
E:\FR\FM\27NON1.SGM
27NON1
7370
2010
9300
Schedule
I
I
II
]]>Agencies
[Federal Register Volume 83, Number 228 (Tuesday, November 27, 2018)]
[Notices]
[Page 60897]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25875]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The registrant listed below has applied for and been granted
registration by the Drug Enforcement Administration (DEA) as bulk a
manufacturer of various classes of schedule I and II controlled
substances.
SUPPLEMENTARY INFORMATION: The company listed below applied to be
registered as bulk manufacturer of various basic classes of controlled
substances. Information on the previously published notice is listed in
the table below. No comments or objections were submitted for this
notice.
------------------------------------------------------------------------
Company FR Docket Published
------------------------------------------------------------------------
Rhodes Technologies.......... 83 FR 40567.... August 15, 2018.
------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of this registrant to manufacture the
applicable basic classes of controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated the company's maintenance of effective
controls against diversion by inspecting and testing the company's
physical security systems, verifying the company's compliance with
state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer
to the above listed company.
Dated: November 16, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-25875 Filed 11-26-18; 8:45 am]
BILLING CODE 4410-09-P
